Postexposure Protection of Guinea Pigs against a Lethal Ebola Virus Challenge Is Conferred by RNA Interference
Author(s) -
Thomas W. Geisbert,
Lisa E. Hensley,
Elliott Kagan,
Erik Z. Yu,
Joan B. Geisbert,
Kathleen M. Daddario-DiCaprio,
Elizabeth A. Fritz,
Peter B. Jahrling,
Kevin McClintock,
Janet R. Phelps,
Amy C. H. Lee,
Adam D. Judge,
Lloyd B. Jeffs,
Ian MacLachlan
Publication year - 2006
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/504267
Subject(s) - ebola virus , virology , rna interference , small interfering rna , virus , biology , viral replication , rna , gene , genetics
Ebola virus (EBOV) infection causes a frequently fatal hemorrhagic fever (HF) that is refractory to treatment with currently available antiviral therapeutics. RNA interference represents a powerful, naturally occurring biological strategy for the inhibition of gene expression and has demonstrated utility in the inhibition of viral replication. Here, we describe the development of a potential therapy for EBOV infection that is based on small interfering RNAs (siRNAs).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom